English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biomarin Pharmaceuticals
Carol Ostrow
| Dec 28, 2017
BioMarin presents revised clinical data for hemophilia A treatment
Ruth de Jauregui
| Jun 8, 2017
BioMarin's Brineura gets European approval for treating CLN2 brain disease in children
Chandra Lye
| May 4, 2017
Drug offers hope for children with rare brain disease
Caitlin Nordahl
| Apr 24, 2017
BioMarin, Par reach settlement on Kuvan
Jeff Gantt
| Dec 18, 2016
BioMarin Pharmaceutical initiates phase 3 vosoritide trial
Amanda Rupp
| May 11, 2016
BioMarin releases EMA grants for Batten disease treatment
Trending
+
Technology/Innovation
Patient Daily
| May 7, 2025
OTO Forum 2025 highlights innovation in ENT
+
Technology/Innovation
Patient Daily
| May 8, 2025
Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+
Pharmaceuticals
Patient Daily
| May 8, 2025
Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+
Pharmaceuticals
Patient Daily
| May 8, 2025
National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments
